FDA Expediting Review of Regeneron Drug to Treat Genetic Hearing Loss
Regeneron’s DB-OTO gene therapy for genetic hearing loss is one of nine drugs to receive expedited review under FDA's new CNPV program.
Category: Hearing Disorders
Hearing Disorders
Latest
Hearing Disorders
Latest
Sensorion Completes Second Cohort Enrollment in OTOF Gene Therapy Clinical Trial
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
Hearing Disorders
Latest
60 Percent of Childhood Hearing Loss Preventable
A new review highlights the underrecognized potential of vaccines to prevent childhood hearing loss, especially in low- and middle-income countries.
Auditory Processing Disorders
Latest
Cilcare Secures Funding to Advance Clinical Trials for Cochlear Synaptopathy Treatment
Cilcare raised €40 million in Series A funding to initiate two clinical trials in 2025 for treatment of cochlear synaptopathy.
Conductive
Latest
‘Discover Magazine’ Article Challenges Notion of Deafness as Something to Be ‘Cured’
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
Sensorineural
Latest
Gold Standard Treatment for Sudden Sensorineural Hearing Loss
In this case study, a man with hearing loss after a stroke benefits from hyperbaric oxygen therapy and steroid treatments.
Meniere’s, Mixed, Syndromic
Latest
Sound Pharma Meniere’s Disease Treatment Phase 3 Study Complete
Sound Pharmaceuticals has completed a Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease, showing potential improvements in hearing loss and tinnitus.